About us

Governing bodies

Board of Governors

  • Chairman

    • Francesc Subirada,

      Director General of Research, Catalan Government (Generalitat de Catalunya)

  • Vice-Chairman

    • José Carlos Fernández Checa,

      Director of Barcelona Biomedical Research Institute.

  • Board members

    • Jordi Alberch,

      Research Vice-Dean of University of Barcelona

    • Antoni Andreu,

      Director General de Recerca i Innovació en Salut - Catalan Government (Generalitat de Catalunya)

    • Lluís Calvo i Calvo,

      Institutional Coordinator of the CSIC in Catalonia

    • Josep M. Campistol,

      General Manager of Hospital Clínic of Barcelona

    • Antoni Castells,

      Medical Director of Hospital Clínic of Barcelona

    • Francesc Cardellach,

      Dean of the University of Barcelona School of Medicine

    • Ramon Gomis,

      Director of IDIBAPS

  • Secretary

    • Lluís Rovira,

      CERCA Director 

Scientific Advisory Board

    • Jesús Ávila, Chairman

      Severo Ochoa Molecular Biology Centre, Madrid

    • Fernando Arenzana-Seisdedos,

      Institut Pasteur, Paris

    • Bartolomé Celli,

      Pulmonary and Critical Care Division, Harvard University, Cambridge

    • Francisco Fernández Avilés,

      Servicio de Cardiología, Hospital Gregorio Marañón, Madrid

    • Guadalupe García-Tsao,

      Clinical and Translational Core, Yale Liver Center, New Haven

    • Roberto Groszmann,

      Hepatic Hemodinamic Lab. Yale University School of Medicine, West Haven

    • José López Barneo,

      Department of Medical Physiology and Biophysics, School of Medicine, Seville

    • Carlos López Otín,

      Department of Biochemistry and Molecular Biology, University of Oviedo

    • Carlos Macaya,

      Servicio de Cardiología, Hospital Clínico San Carlos, Madrid

    • José M. Mato,

      Cooperative Bioscience Research Centre (CIC bioGUNE), Biscay

    • Federico Mayor,

      Severo Ochoa Molecular Biology Centre, Madrid

    • Ángel Pellicer,

      NYU School of Medicine

    • Miguel Ángel del Pozo,

      Integrin Signalling Laboratory, National Cardiovascular Research Centre (CNIC), Madrid

    • Ciril Rozman,

      Haematology Department, Hospital Clínic de Barcelona, University of Barcelona

    • Jesús San Miguel,

      Haematology Department, Hospital Clínico de Salamanca

    • Francisco Sánchez-Madrid,

      Immunology Department, Hospital La Princesa, Madrid

    • Eugenio Santos,

      Cancer Research Centre, Salamanca

    • Antonio Vidal-Puig,

      Department of Clinical Biochemistry, School of Clinical Medicine, University of Cambridge